1-7 of 7
Erika A. Eksioglu
Close
Sort by
Journal Articles

TLR9-Selective Therapeutic Targeting of MDS Clones with a CpG Payload-Delivery Strategy

Grace A Ward, Sean Christiansen, Gabriela Wright, Sheng Wei, Alan F. List, Kenneth Wright, Erika A Eksioglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12306–12307.
https://doi.org/10.1182/blood-2022-170340
Published: 2022
Journal Articles

TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

David A. Sallman, Amy F. McLemore, Amy L. Aldrich, Rami S. Komrokji, Kathy L. McGraw, Abhishek Dhawan, Susan Geyer, Hsin-An Hou, Erika A. Eksioglu, Amy Sullivan, Sarah Warren, Kyle J. MacBeth, Manja Meggendorfer, Torsten Haferlach, Steffen Boettcher, Benjamin L. Ebert, Najla H. Al Ali, Jeffrey E. Lancet, John L. Cleveland, Eric Padron, Alan F. List
Journal: Blood
Blood (2020) 136 (24): 2812–2823.
https://doi.org/10.1182/blood.2020006158
Published: 2020
Includes: Supplemental data
Journal Articles

Genomic-DNA Exposed By Somatic Gene Mutations Engages the cGAS/STING Axis to License the NLRP3 Inflammasome in Myelodysplastic Syndromes

Amy F McLemore, M.S., Kathy L McGraw, PhD, Hsin-An Hou, MD PhD, Grace A Ward, BS, Alexis H Onimus, BS, Nicole D. Vincelette, PhD, Matthew A. Rodrigues, PhD, Neelkamal Chaudhary, PhD, Ling Zhang, MD, Benjamin S. Meyer, Erika A Eksioglu, PhD MS, Sheng Wei, MD, Alan F. List, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3075.
https://doi.org/10.1182/blood-2018-99-116929
Published: 2018
Journal Articles

Oxidized Mitochondrial DNA Is a Catalyst and Biomarker of Pyroptotic Cell Death in Myelodysplastic Syndromes

Grace A Ward, BS, Kathy L McGraw, PhD, Amy F McLemore, M.S., Farnoosh Abbas-Aghababazadeh, PhD, Hsin-An Hou, MD PhD, Thu Le Trinh, PhD, Nicole D. Vincelette, PhD, Benjamin S. Meyer, Alexis H Onimus, BS, Alexandra Calescibetta, Erika A Eksioglu, PhD MS, Sheng Wei, MD, Alan F. List, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3076.
https://doi.org/10.1182/blood-2018-99-118493
Published: 2018
Journal Articles

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu, Xianghong Chen, Joseph Johnson, Ling Zhang, Qing Zhang, Brittany A. Irvine, Thomas Cluzeau, David A. Sallman, Eric Padron, Rami Komrokji, Lubomir Sokol, Rebecca C. Coll, Avril A. B. Robertson, Matthew A. Cooper, John L. Cleveland, Luke A. O’Neill, Sheng Wei, Alan F. List
Journal: Blood
Blood (2016) 128 (25): 2960–2975.
https://doi.org/10.1182/blood-2016-07-730556
Published: 2016
Includes: Supplemental data
Journal Articles

Novel Therapeutic Approach to Improve Hematopoiesis By Targeting Myeloid Derived Suppressor Cells with a Humanized Anti-CD33 Antibody

Erika A Eksioglu, PhD, Karl-Heinz Heider, PhD, Bjoern Rueter, MD, Alexis Burnette, Max Wei, Kathy McGraw, Ashley A Basiorka, Parthik Patel, Jeffrey Lancet, Rami Komrokji, MD, Alan F. List, MD, Sheng Wei, MD
Journal: Blood
Blood (2014) 124 (21): 4597.
https://doi.org/10.1182/blood.V124.21.4597.4597
Published: 2014
Journal Articles

Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC)

Sheng Wei, MD, Xianghong Chen, Junmin Zhou, Ph.D, Ling Zhang, MD, Nicole R. Fortenbery, Sarah S Rasche, Ph.D, Kathy McGraw, Erika A. Eksioglu, Ph.D, P.K. Epling-Burnette, PhD, Julie Y. Djeu, Ph.D, Dmitry I. Gabrilovich, Ph.D, Alan F. List, MD
Journal: Blood
Blood (2011) 118 (21): 788.
https://doi.org/10.1182/blood.V118.21.788.788
Published: 2011